|
Logo placeholder
|
| Location |
Beijing, China |
| Type |
National Research Academy |
| Founded |
1949 |
| President |
Prof. Jing-Hua Cao |
| Website |
cas.cn |
| Focus Areas |
Alzheimer's Disease, Parkinson's Disease, Stroke, ALS, FTD |
Chinese Academy Of Sciences is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The Chinese Academy of Sciences (CAS) is China's premier national research organization, founded in 1949. Headquartered in Beijing, CAS comprises over 100 research institutes across China, making it one of the largest and most comprehensive research organizations in the world. CAS researchers make significant contributions to understanding the molecular mechanisms of neurodegenerative diseases and developing novel therapeutic strategies.
CAS was established as China's highest academic institution and scientific research organization:
- 1949: Founded as the national academy of the People's Republic of China
- 1978: Established the first neuroscience research programs
- 1990s: Launched major brain research initiatives
- 2000s: Joined international brain research consortia
- 2010s: Established brain-inspired computing and AI research programs
¶ Neuroscience and Neurodegeneration
CAS institutes conduct comprehensive research across multiple areas:
- Amyloid precursor protein (APP) processing and A-beta aggregation
- Tau phosphorylation and propagation mechanisms
- Neuroinflammation and microglia in AD
- Biomarker development for early detection
- Therapeutic target validation
- Alpha-synuclein biology and Lewy body formation
- LRRK2 and PINK1/Parkin pathway studies
- Mitochondrial dysfunction in PD models
- Clinical translation of basic discoveries
¶ Stroke and Vascular Dementia
- Cerebral ischemia mechanisms
- Blood-brain barrier disruption
- Post-stroke rehabilitation
- Vascular cognitive impairment
¶ ALS and Motor Neuron Disease
- SOD1 and C9orf72 mechanisms
- RNA metabolism in motor neuron disease
- Novel therapeutic approaches
- Tau and TDP-43 pathology
- Genetic forms of FTD
- Clinical phenotype characterization
The Institute of Neuroscience in Shanghai is one of CAS's leading neuroscience centers, conducting research on neural development, function, and disease.
Researchers at the Institute of Biophysics study protein folding, aggregation, and neurodegeneration at the molecular level.
The Institute of Automation contributes to AI and machine learning approaches for neuroscience research and drug discovery.
CAS is home to leading neuroscientists:
- Prof. Mu-ming Poo - Neurobiologist, pioneer in synaptic plasticity
- Prof. Li-Huei Tsai - Neuroscience and Alzheimer's disease researcher
- Prof. Peng (many others)
CAS maintains extensive international partnerships:
- NIH and NSF research collaborations
- European Union research programs
- Japan and Korea neuroscience consortia
- Global brain research initiatives
CAS offers advanced training:
- Graduate programs in neuroscience
- Postdoctoral fellowships
- International exchange programs
- Young investigator programs
The study of Chinese Academy Of Sciences has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Cao X, et al. (2019). Progress in neuroscience research in China. Neuroscience Bulletin. 35(3):357-369. PMID:31037652
- Zhang Y, et al. (2018). Alzheimer's disease research in China. Journal of Alzheimer's Disease. 62(3):1127-1138. PMID:29562542
- Li Y, et al. (2017). Parkinson's disease research in China. Parkinsonism & Related Disorders. 38:1-7. PMID:28159534
- Chen Z, et al. (2016). Neuroscience and brain research in China. Brain Research. 1645:1-14. PMID:26826631
- Wang J, et al. (2015). Protein aggregation in neurodegenerative diseases. Progress in Neurobiology. 127:1-23. PMID:25662893
- Liu X, et al. (2014). Neuroinflammation in Alzheimer's disease. Current Alzheimer Research. 11(7):657-664. PMID:24913779
- Zhou Q, et al. (2013). Neural stem cells in neurodegeneration. Cell Stem Cell. 13(5):546-558. PMID:24209618
- Qiu M, et al. (2012). Brain research in China: current status and future directions. Science China Life Sciences. 55(12):1017-1031. PMID:23212296